Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Radiography, Abdominal | 21 | 2015 | 543 | 2.640 |
Why?
|
Contrast Media | 78 | 2024 | 5330 | 2.200 |
Why?
|
Liver Neoplasms | 75 | 2020 | 4352 | 2.000 |
Why?
|
Tomography, X-Ray Computed | 97 | 2024 | 20700 | 1.880 |
Why?
|
Tomography, Spiral Computed | 11 | 2005 | 273 | 1.640 |
Why?
|
Magnetic Resonance Imaging | 116 | 2024 | 36548 | 1.430 |
Why?
|
Liver Diseases | 30 | 2020 | 1304 | 1.120 |
Why?
|
Oxides | 19 | 2003 | 402 | 1.060 |
Why?
|
Liver | 53 | 2020 | 7559 | 1.020 |
Why?
|
Radiology Department, Hospital | 6 | 2022 | 409 | 1.020 |
Why?
|
Tomography Scanners, X-Ray Computed | 9 | 2007 | 170 | 0.960 |
Why?
|
Radiation Dosage | 23 | 2015 | 1945 | 0.900 |
Why?
|
Edetic Acid | 11 | 2009 | 274 | 0.870 |
Why?
|
Pelvis | 7 | 2007 | 737 | 0.780 |
Why?
|
Pyridoxal Phosphate | 10 | 2009 | 123 | 0.770 |
Why?
|
Hemangioma | 18 | 2016 | 724 | 0.750 |
Why?
|
Organometallic Compounds | 14 | 2009 | 645 | 0.730 |
Why?
|
Meglumine | 8 | 2009 | 143 | 0.710 |
Why?
|
Diagnostic Imaging | 13 | 2023 | 3530 | 0.680 |
Why?
|
Radiology | 14 | 2023 | 2105 | 0.670 |
Why?
|
Iron | 19 | 2003 | 1811 | 0.650 |
Why?
|
Angiography | 7 | 2007 | 1589 | 0.640 |
Why?
|
Carcinoma, Hepatocellular | 17 | 2014 | 2327 | 0.600 |
Why?
|
Radiometry | 5 | 2005 | 804 | 0.550 |
Why?
|
Image Enhancement | 16 | 2016 | 2857 | 0.530 |
Why?
|
Technology, Radiologic | 3 | 2004 | 158 | 0.510 |
Why?
|
Abdomen | 12 | 2020 | 1135 | 0.480 |
Why?
|
Image Processing, Computer-Assisted | 23 | 2012 | 8924 | 0.480 |
Why?
|
Simethicone | 3 | 2003 | 15 | 0.460 |
Why?
|
Kidney Calculi | 3 | 2022 | 458 | 0.460 |
Why?
|
Radiographic Image Enhancement | 9 | 2020 | 873 | 0.440 |
Why?
|
Cellulose | 3 | 2003 | 116 | 0.440 |
Why?
|
Hematuria | 3 | 2004 | 232 | 0.430 |
Why?
|
Pancreatic Diseases | 7 | 2019 | 353 | 0.420 |
Why?
|
Phantoms, Imaging | 8 | 2009 | 2474 | 0.410 |
Why?
|
Biliary Tract Diseases | 4 | 2010 | 160 | 0.410 |
Why?
|
Gadolinium | 14 | 2006 | 966 | 0.410 |
Why?
|
Pancreatic Neoplasms | 14 | 2021 | 5454 | 0.400 |
Why?
|
Gadolinium DTPA | 11 | 2016 | 822 | 0.380 |
Why?
|
Artifacts | 14 | 2009 | 1896 | 0.360 |
Why?
|
Peer Review | 2 | 2023 | 217 | 0.360 |
Why?
|
Decision Support Systems, Clinical | 3 | 2024 | 1177 | 0.350 |
Why?
|
Cholestasis | 9 | 2002 | 385 | 0.330 |
Why?
|
Neoplasms, Radiation-Induced | 2 | 2004 | 540 | 0.320 |
Why?
|
Humans | 258 | 2024 | 766117 | 0.310 |
Why?
|
Ferric Compounds | 9 | 2001 | 367 | 0.310 |
Why?
|
Safety | 4 | 2010 | 1157 | 0.300 |
Why?
|
Aged | 113 | 2024 | 171219 | 0.300 |
Why?
|
Cholangiopancreatography, Endoscopic Retrograde | 8 | 2004 | 520 | 0.290 |
Why?
|
Efficiency, Organizational | 4 | 2009 | 695 | 0.290 |
Why?
|
Adenoma, Liver Cell | 4 | 2014 | 32 | 0.290 |
Why?
|
Ferrosoferric Oxide | 18 | 2003 | 349 | 0.290 |
Why?
|
Cholangiography | 8 | 2015 | 182 | 0.280 |
Why?
|
Abdominal Neoplasms | 7 | 2004 | 286 | 0.280 |
Why?
|
Middle Aged | 123 | 2024 | 223083 | 0.280 |
Why?
|
Commerce | 1 | 2012 | 612 | 0.280 |
Why?
|
Echo-Planar Imaging | 7 | 1996 | 649 | 0.280 |
Why?
|
Magnetite Nanoparticles | 16 | 2003 | 309 | 0.270 |
Why?
|
Digestive System | 4 | 2003 | 244 | 0.270 |
Why?
|
Radiology, Interventional | 3 | 2023 | 484 | 0.270 |
Why?
|
Hernia, Diaphragmatic | 2 | 2005 | 244 | 0.260 |
Why?
|
Dextrans | 16 | 2003 | 569 | 0.260 |
Why?
|
Time Management | 2 | 2005 | 53 | 0.260 |
Why?
|
Statistics, Nonparametric | 10 | 2006 | 2844 | 0.260 |
Why?
|
Sensitivity and Specificity | 28 | 2020 | 14645 | 0.260 |
Why?
|
Urography | 4 | 2004 | 316 | 0.260 |
Why?
|
Renal Artery | 2 | 2007 | 355 | 0.250 |
Why?
|
Incidental Findings | 3 | 2005 | 698 | 0.250 |
Why?
|
Adenocarcinoma | 9 | 2019 | 6363 | 0.250 |
Why?
|
Cholangiocarcinoma | 5 | 2003 | 577 | 0.240 |
Why?
|
Magnetic Resonance Angiography | 6 | 2004 | 1429 | 0.240 |
Why?
|
Male | 136 | 2024 | 363935 | 0.240 |
Why?
|
Patient Preference | 1 | 2012 | 947 | 0.240 |
Why?
|
Lithotripsy | 5 | 2020 | 137 | 0.230 |
Why?
|
Adult | 104 | 2024 | 223139 | 0.230 |
Why?
|
Private Practice | 2 | 2015 | 154 | 0.230 |
Why?
|
Female | 139 | 2024 | 396233 | 0.220 |
Why?
|
Preoperative Care | 8 | 2011 | 2249 | 0.220 |
Why?
|
Emergency Service, Hospital | 7 | 2024 | 7871 | 0.220 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 3 | 2015 | 1225 | 0.220 |
Why?
|
Ureteral Calculi | 1 | 2005 | 111 | 0.220 |
Why?
|
Retrospective Studies | 54 | 2024 | 81565 | 0.220 |
Why?
|
Ultrasonography | 20 | 2015 | 5988 | 0.220 |
Why?
|
Cysts | 8 | 1997 | 684 | 0.220 |
Why?
|
Thorium Dioxide | 1 | 2003 | 18 | 0.210 |
Why?
|
Early Detection of Cancer | 2 | 2020 | 3238 | 0.210 |
Why?
|
Aorta, Abdominal | 1 | 2006 | 626 | 0.210 |
Why?
|
Diagnosis, Differential | 26 | 2020 | 12976 | 0.210 |
Why?
|
Aged, 80 and over | 48 | 2021 | 59515 | 0.210 |
Why?
|
Manganese | 6 | 2005 | 395 | 0.210 |
Why?
|
Body Weights and Measures | 1 | 2003 | 208 | 0.210 |
Why?
|
Cystadenoma, Mucinous | 1 | 2003 | 62 | 0.210 |
Why?
|
Referral and Consultation | 1 | 2016 | 3617 | 0.210 |
Why?
|
Urinary Tract | 2 | 2004 | 305 | 0.200 |
Why?
|
Hip Prosthesis | 2 | 2005 | 895 | 0.200 |
Why?
|
Observer Variation | 11 | 2015 | 2611 | 0.200 |
Why?
|
Urinary Calculi | 1 | 2002 | 81 | 0.200 |
Why?
|
Calcium Oxalate | 1 | 2022 | 75 | 0.200 |
Why?
|
Colonic Neoplasms | 6 | 2006 | 2532 | 0.200 |
Why?
|
Mitochondrial Membranes | 1 | 2023 | 184 | 0.200 |
Why?
|
Liver Cirrhosis | 6 | 2020 | 1961 | 0.190 |
Why?
|
Mammography | 1 | 2012 | 2424 | 0.190 |
Why?
|
Carcinoma, Acinar Cell | 1 | 2002 | 62 | 0.190 |
Why?
|
Equipment Safety | 1 | 2022 | 250 | 0.190 |
Why?
|
Unnecessary Procedures | 1 | 2004 | 412 | 0.180 |
Why?
|
Radiation Protection | 4 | 2010 | 424 | 0.180 |
Why?
|
Adrenal Gland Neoplasms | 5 | 2019 | 731 | 0.170 |
Why?
|
Cholelithiasis | 8 | 1992 | 408 | 0.170 |
Why?
|
Phospholipids | 1 | 2023 | 776 | 0.160 |
Why?
|
Terminology as Topic | 1 | 2006 | 1536 | 0.160 |
Why?
|
Prostheses and Implants | 2 | 2005 | 1273 | 0.160 |
Why?
|
Faculty | 1 | 2022 | 383 | 0.160 |
Why?
|
Chelating Agents | 2 | 2000 | 380 | 0.160 |
Why?
|
Liver Transplantation | 7 | 2011 | 2417 | 0.160 |
Why?
|
Abdominal Abscess | 1 | 2000 | 152 | 0.160 |
Why?
|
Positron-Emission Tomography | 2 | 2005 | 6545 | 0.160 |
Why?
|
Academic Medical Centers | 4 | 2020 | 2782 | 0.150 |
Why?
|
Urologic Neoplasms | 1 | 2002 | 312 | 0.150 |
Why?
|
Bile Ducts | 4 | 2015 | 288 | 0.150 |
Why?
|
Histiocytoma, Benign Fibrous | 1 | 1998 | 64 | 0.150 |
Why?
|
Radiography | 9 | 2023 | 6943 | 0.150 |
Why?
|
Pelvic Neoplasms | 4 | 2004 | 248 | 0.150 |
Why?
|
Kidney | 6 | 2022 | 7072 | 0.140 |
Why?
|
Adenoma | 5 | 2004 | 2155 | 0.140 |
Why?
|
Bile Duct Diseases | 2 | 2015 | 98 | 0.140 |
Why?
|
Fatty Liver | 3 | 2020 | 810 | 0.140 |
Why?
|
Body Weight | 4 | 2004 | 4626 | 0.140 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2005 | 958 | 0.140 |
Why?
|
Research | 2 | 1996 | 1975 | 0.140 |
Why?
|
Neuroendocrine Tumors | 1 | 2003 | 657 | 0.140 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2014 | 9378 | 0.140 |
Why?
|
Radiation Injuries | 1 | 2004 | 1181 | 0.140 |
Why?
|
Appointments and Schedules | 2 | 2020 | 441 | 0.140 |
Why?
|
Equipment Design | 5 | 2004 | 3489 | 0.130 |
Why?
|
Mass Screening | 1 | 2012 | 5450 | 0.130 |
Why?
|
Pancreatitis | 6 | 2004 | 1086 | 0.130 |
Why?
|
Hospitals, Military | 1 | 2016 | 62 | 0.130 |
Why?
|
Urinary Tract Infections | 1 | 2002 | 804 | 0.130 |
Why?
|
Outpatients | 3 | 2022 | 1596 | 0.130 |
Why?
|
Job Description | 1 | 2015 | 61 | 0.130 |
Why?
|
Informed Consent | 1 | 2022 | 1010 | 0.130 |
Why?
|
Living Donors | 3 | 2005 | 647 | 0.130 |
Why?
|
Pandemics | 5 | 2023 | 8725 | 0.130 |
Why?
|
Pancreatic Cyst | 3 | 2005 | 373 | 0.120 |
Why?
|
Pancreas | 9 | 2019 | 1699 | 0.120 |
Why?
|
Benchmarking | 2 | 2021 | 1055 | 0.120 |
Why?
|
Documentation | 1 | 2022 | 911 | 0.120 |
Why?
|
Hospitals, Rural | 1 | 2017 | 175 | 0.120 |
Why?
|
Gastrostomy | 3 | 1997 | 325 | 0.120 |
Why?
|
Radiology Information Systems | 3 | 2016 | 535 | 0.120 |
Why?
|
Kidney Transplantation | 2 | 2007 | 4277 | 0.110 |
Why?
|
Utilization Review | 1 | 2016 | 381 | 0.110 |
Why?
|
Portal Vein | 5 | 2004 | 437 | 0.110 |
Why?
|
Efficiency | 3 | 2009 | 479 | 0.110 |
Why?
|
Fees and Charges | 1 | 2015 | 189 | 0.110 |
Why?
|
Infusion Pumps, Implantable | 2 | 2004 | 158 | 0.110 |
Why?
|
Trauma Centers | 2 | 2017 | 950 | 0.110 |
Why?
|
Lymphatic Diseases | 2 | 2013 | 317 | 0.110 |
Why?
|
Hospital Costs | 1 | 2000 | 955 | 0.110 |
Why?
|
Telephone | 1 | 2017 | 627 | 0.110 |
Why?
|
Costs and Cost Analysis | 6 | 2020 | 1666 | 0.110 |
Why?
|
Male Urogenital Diseases | 1 | 2013 | 48 | 0.110 |
Why?
|
Infection Control | 1 | 2020 | 984 | 0.110 |
Why?
|
Health Facility Planning | 1 | 2012 | 19 | 0.100 |
Why?
|
Radiography, Thoracic | 4 | 2004 | 1319 | 0.100 |
Why?
|
Capital Expenditures | 1 | 2012 | 27 | 0.100 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3111 | 0.100 |
Why?
|
Mammary Neoplasms, Experimental | 2 | 1995 | 496 | 0.100 |
Why?
|
Biliary Tract | 5 | 2004 | 137 | 0.100 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3233 | 0.100 |
Why?
|
Hemangioma, Cavernous | 6 | 1993 | 106 | 0.100 |
Why?
|
Consumer Health Information | 1 | 2015 | 215 | 0.100 |
Why?
|
Metals | 4 | 2005 | 709 | 0.100 |
Why?
|
Iohexol | 2 | 2024 | 205 | 0.100 |
Why?
|
Hepatic Veins | 3 | 2004 | 112 | 0.100 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2003 | 1762 | 0.100 |
Why?
|
Imaging, Three-Dimensional | 6 | 2016 | 4044 | 0.100 |
Why?
|
Digestive System Diseases | 1 | 2013 | 152 | 0.100 |
Why?
|
Gastrointestinal Diseases | 1 | 2020 | 1204 | 0.090 |
Why?
|
Boston | 6 | 2017 | 9335 | 0.090 |
Why?
|
Infusions, Parenteral | 1 | 1991 | 395 | 0.090 |
Why?
|
Reproducibility of Results | 10 | 2007 | 20137 | 0.090 |
Why?
|
Societies, Medical | 2 | 2015 | 3955 | 0.090 |
Why?
|
Catheterization | 9 | 2002 | 1426 | 0.090 |
Why?
|
Pulmonary Embolism | 1 | 2024 | 2596 | 0.090 |
Why?
|
Electronic Health Records | 2 | 2022 | 4863 | 0.090 |
Why?
|
Organizational Objectives | 1 | 2012 | 426 | 0.090 |
Why?
|
Medical Order Entry Systems | 1 | 2016 | 523 | 0.090 |
Why?
|
Predictive Value of Tests | 7 | 2022 | 15403 | 0.090 |
Why?
|
Algorithms | 3 | 2005 | 14066 | 0.090 |
Why?
|
Hepatic Artery | 4 | 2004 | 233 | 0.080 |
Why?
|
Relative Value Scales | 2 | 2000 | 85 | 0.080 |
Why?
|
Patient Protection and Affordable Care Act | 1 | 2020 | 1188 | 0.080 |
Why?
|
Radiography, Interventional | 5 | 2000 | 1128 | 0.080 |
Why?
|
Sarcoidosis | 1 | 2015 | 535 | 0.080 |
Why?
|
Liver Circulation | 2 | 2002 | 163 | 0.080 |
Why?
|
Nephrogenic Fibrosing Dermopathy | 1 | 2009 | 42 | 0.080 |
Why?
|
Neoplasms | 4 | 2023 | 22344 | 0.080 |
Why?
|
Spleen | 5 | 2001 | 2294 | 0.080 |
Why?
|
Splenic Diseases | 2 | 2001 | 91 | 0.080 |
Why?
|
Taxoids | 2 | 2003 | 665 | 0.080 |
Why?
|
Employee Performance Appraisal | 1 | 2009 | 86 | 0.080 |
Why?
|
Employment | 1 | 2015 | 1108 | 0.080 |
Why?
|
Massachusetts | 6 | 2021 | 8882 | 0.080 |
Why?
|
Head | 1 | 2015 | 926 | 0.080 |
Why?
|
Patient Transfer | 1 | 2016 | 789 | 0.080 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2017 | 949 | 0.080 |
Why?
|
Breast Neoplasms | 4 | 2012 | 21074 | 0.080 |
Why?
|
Ultrasonography, Interventional | 1 | 2017 | 1520 | 0.080 |
Why?
|
Artificial Intelligence | 1 | 2023 | 2662 | 0.080 |
Why?
|
Deoxycytidine | 2 | 2003 | 886 | 0.070 |
Why?
|
Adenoma, Bile Duct | 4 | 1992 | 29 | 0.070 |
Why?
|
Pentetic Acid | 5 | 1996 | 208 | 0.070 |
Why?
|
Hepatectomy | 3 | 2011 | 588 | 0.070 |
Why?
|
Clinical Trials as Topic | 2 | 2001 | 8038 | 0.070 |
Why?
|
Fluorodeoxyglucose F18 | 3 | 2005 | 2029 | 0.070 |
Why?
|
Neoplasms, Second Primary | 1 | 2016 | 1056 | 0.070 |
Why?
|
Conscious Sedation | 1 | 2012 | 534 | 0.070 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2022 | 2306 | 0.070 |
Why?
|
Infusions, Intra-Arterial | 2 | 2004 | 219 | 0.070 |
Why?
|
Autoimmune Diseases | 2 | 2013 | 2249 | 0.070 |
Why?
|
Radiography, Dual-Energy Scanned Projection | 2 | 2020 | 208 | 0.070 |
Why?
|
Magnetics | 3 | 1990 | 586 | 0.070 |
Why?
|
Models, Theoretical | 2 | 2015 | 3561 | 0.070 |
Why?
|
Bile Duct Neoplasms | 4 | 1994 | 624 | 0.070 |
Why?
|
Radiopharmaceuticals | 3 | 2005 | 2702 | 0.070 |
Why?
|
Age Distribution | 1 | 2012 | 2865 | 0.070 |
Why?
|
ROC Curve | 9 | 2003 | 3614 | 0.070 |
Why?
|
Iron Overload | 2 | 2020 | 245 | 0.070 |
Why?
|
Indoles | 1 | 1995 | 1833 | 0.070 |
Why?
|
Practice Guidelines as Topic | 4 | 2014 | 7424 | 0.070 |
Why?
|
Common Bile Duct Neoplasms | 2 | 2002 | 121 | 0.070 |
Why?
|
Rectal Neoplasms | 3 | 2005 | 1183 | 0.070 |
Why?
|
Lymphatic Metastasis | 3 | 2003 | 2890 | 0.060 |
Why?
|
Prostatic Neoplasms | 3 | 2024 | 11094 | 0.060 |
Why?
|
Low Back Pain | 1 | 2014 | 987 | 0.060 |
Why?
|
Analysis of Variance | 3 | 2009 | 6208 | 0.060 |
Why?
|
Endoscopy, Gastrointestinal | 1 | 2012 | 889 | 0.060 |
Why?
|
Mesenteric Artery, Superior | 1 | 2006 | 96 | 0.060 |
Why?
|
Punctures | 4 | 1997 | 372 | 0.060 |
Why?
|
Administration, Oral | 3 | 2003 | 4016 | 0.060 |
Why?
|
Radionuclide Imaging | 3 | 2000 | 1985 | 0.060 |
Why?
|
Paclitaxel | 2 | 2003 | 1727 | 0.060 |
Why?
|
Gallstones | 2 | 2002 | 285 | 0.060 |
Why?
|
Economics, Medical | 1 | 2005 | 112 | 0.060 |
Why?
|
Mesentery | 1 | 2005 | 200 | 0.060 |
Why?
|
Educational Status | 1 | 2012 | 2510 | 0.060 |
Why?
|
United States | 13 | 2020 | 72920 | 0.060 |
Why?
|
Cholecystostomy | 4 | 1992 | 54 | 0.060 |
Why?
|
Iliac Artery | 1 | 2006 | 344 | 0.060 |
Why?
|
Biopsy, Needle | 4 | 1992 | 1613 | 0.060 |
Why?
|
Patient Satisfaction | 1 | 2017 | 3477 | 0.060 |
Why?
|
Tissue and Organ Harvesting | 2 | 2004 | 373 | 0.060 |
Why?
|
Guideline Adherence | 1 | 2014 | 2235 | 0.060 |
Why?
|
Critical Care | 1 | 2017 | 2714 | 0.060 |
Why?
|
Stents | 5 | 1994 | 3191 | 0.060 |
Why?
|
Body Burden | 1 | 2004 | 156 | 0.060 |
Why?
|
Splenic Neoplasms | 3 | 1989 | 97 | 0.060 |
Why?
|
Renal Insufficiency | 1 | 2009 | 810 | 0.060 |
Why?
|
Evaluation Studies as Topic | 5 | 2020 | 1607 | 0.050 |
Why?
|
Biopsy | 6 | 2024 | 6768 | 0.050 |
Why?
|
Workload | 1 | 2009 | 849 | 0.050 |
Why?
|
Kidney Pelvis | 1 | 2005 | 191 | 0.050 |
Why?
|
Iodine | 1 | 2006 | 285 | 0.050 |
Why?
|
Diabetes Mellitus | 1 | 2022 | 5889 | 0.050 |
Why?
|
Cardiolipins | 1 | 2023 | 82 | 0.050 |
Why?
|
Thyroid Neoplasms | 1 | 2017 | 2354 | 0.050 |
Why?
|
Wounds and Injuries | 1 | 2016 | 2513 | 0.050 |
Why?
|
Immunoglobulin G | 2 | 2013 | 4556 | 0.050 |
Why?
|
Cystic Duct | 2 | 1992 | 17 | 0.050 |
Why?
|
Diaphragm | 1 | 2005 | 357 | 0.050 |
Why?
|
Liver Abscess | 2 | 1997 | 81 | 0.050 |
Why?
|
Drainage | 6 | 1993 | 1182 | 0.050 |
Why?
|
Acute Disease | 8 | 2005 | 7237 | 0.050 |
Why?
|
Cholecystitis | 3 | 2002 | 181 | 0.050 |
Why?
|
Stomach | 3 | 2004 | 702 | 0.050 |
Why?
|
Women's Health | 1 | 2012 | 2081 | 0.050 |
Why?
|
Lung Neoplasms | 3 | 2020 | 13483 | 0.050 |
Why?
|
Program Development | 2 | 2020 | 1297 | 0.050 |
Why?
|
Prospective Studies | 14 | 2015 | 54812 | 0.050 |
Why?
|
Gallbladder | 4 | 1992 | 308 | 0.050 |
Why?
|
Oxalates | 1 | 2022 | 99 | 0.050 |
Why?
|
Hemorrhage | 1 | 1994 | 3466 | 0.050 |
Why?
|
Forecasting | 2 | 2002 | 2936 | 0.050 |
Why?
|
Hepatic Duct, Common | 2 | 1993 | 48 | 0.050 |
Why?
|
Quality Improvement | 1 | 2017 | 3849 | 0.050 |
Why?
|
Tissue Donors | 2 | 2007 | 2392 | 0.050 |
Why?
|
Lymphography | 1 | 2002 | 189 | 0.050 |
Why?
|
Vascular Diseases | 1 | 2010 | 1161 | 0.050 |
Why?
|
Bile Ducts, Intrahepatic | 2 | 1993 | 307 | 0.050 |
Why?
|
Ampulla of Vater | 1 | 2002 | 150 | 0.050 |
Why?
|
Ambulatory Care | 1 | 2012 | 2778 | 0.050 |
Why?
|
Feasibility Studies | 6 | 2017 | 5300 | 0.050 |
Why?
|
Kidney Diseases, Cystic | 1 | 2002 | 182 | 0.050 |
Why?
|
Urologic Diseases | 1 | 2004 | 245 | 0.050 |
Why?
|
Time Factors | 9 | 2007 | 40108 | 0.050 |
Why?
|
Heterocyclic Compounds | 2 | 1995 | 245 | 0.050 |
Why?
|
Oxidative Phosphorylation | 1 | 2023 | 502 | 0.050 |
Why?
|
Sclerotherapy | 2 | 1992 | 184 | 0.050 |
Why?
|
Endoscopy | 2 | 2010 | 1854 | 0.040 |
Why?
|
Pilot Projects | 4 | 2020 | 8724 | 0.040 |
Why?
|
Thoracic Neoplasms | 1 | 2003 | 268 | 0.040 |
Why?
|
Leadership | 1 | 2010 | 1394 | 0.040 |
Why?
|
Tomography, Emission-Computed | 1 | 2003 | 1006 | 0.040 |
Why?
|
Iodine Compounds | 1 | 2020 | 28 | 0.040 |
Why?
|
Laser Coagulation | 2 | 1992 | 334 | 0.040 |
Why?
|
Program Evaluation | 2 | 2020 | 2502 | 0.040 |
Why?
|
Lymphoma | 3 | 2003 | 1896 | 0.040 |
Why?
|
Diverticulitis, Colonic | 1 | 2002 | 140 | 0.040 |
Why?
|
Patient Selection | 1 | 2012 | 4249 | 0.040 |
Why?
|
Arm | 1 | 2003 | 590 | 0.040 |
Why?
|
Acetabulum | 1 | 2004 | 542 | 0.040 |
Why?
|
Common Bile Duct | 2 | 1991 | 106 | 0.040 |
Why?
|
Emergency Medical Services | 2 | 2014 | 1937 | 0.040 |
Why?
|
Adolescent | 14 | 2020 | 88819 | 0.040 |
Why?
|
Abdominal Pain | 1 | 2006 | 1069 | 0.040 |
Why?
|
Lymph Nodes | 4 | 2003 | 3456 | 0.040 |
Why?
|
Random Allocation | 1 | 2004 | 2395 | 0.040 |
Why?
|
Infusions, Intravenous | 3 | 2003 | 2227 | 0.040 |
Why?
|
Patient-Centered Care | 2 | 2020 | 1447 | 0.040 |
Why?
|
Urban Health Services | 1 | 2020 | 176 | 0.040 |
Why?
|
Prevalence | 3 | 2012 | 15827 | 0.040 |
Why?
|
Health Services Accessibility | 1 | 2017 | 5510 | 0.040 |
Why?
|
Posture | 1 | 2003 | 955 | 0.040 |
Why?
|
Probability | 1 | 2024 | 2475 | 0.040 |
Why?
|
Phosphates | 1 | 2022 | 763 | 0.040 |
Why?
|
Patient Care Planning | 1 | 2004 | 903 | 0.040 |
Why?
|
Child | 12 | 2015 | 80573 | 0.040 |
Why?
|
Socioeconomic Factors | 1 | 2012 | 7843 | 0.040 |
Why?
|
Tissue Distribution | 4 | 2001 | 2271 | 0.040 |
Why?
|
Critical Pathways | 1 | 2002 | 475 | 0.040 |
Why?
|
Prosthesis Design | 1 | 2005 | 2111 | 0.040 |
Why?
|
Barium Sulfate | 3 | 1995 | 180 | 0.040 |
Why?
|
Risk Factors | 6 | 2022 | 74857 | 0.040 |
Why?
|
Laparotomy | 1 | 2020 | 459 | 0.040 |
Why?
|
Needles | 3 | 1989 | 460 | 0.040 |
Why?
|
Hospitals | 2 | 2021 | 3887 | 0.040 |
Why?
|
Organizational Innovation | 1 | 2020 | 540 | 0.040 |
Why?
|
APACHE | 1 | 1997 | 268 | 0.030 |
Why?
|
Ischemia | 1 | 2005 | 1904 | 0.030 |
Why?
|
Cohort Studies | 4 | 2015 | 41684 | 0.030 |
Why?
|
Uric Acid | 1 | 2022 | 809 | 0.030 |
Why?
|
Colon | 2 | 1995 | 1797 | 0.030 |
Why?
|
Aortic Aneurysm, Abdominal | 1 | 2006 | 1249 | 0.030 |
Why?
|
Organizational Case Studies | 1 | 2017 | 301 | 0.030 |
Why?
|
Young Adult | 4 | 2020 | 59868 | 0.030 |
Why?
|
Prostate | 1 | 2024 | 1758 | 0.030 |
Why?
|
Biliary Tract Neoplasms | 1 | 1997 | 186 | 0.030 |
Why?
|
Digestive System Physiological Phenomena | 1 | 1995 | 15 | 0.030 |
Why?
|
Fluoroscopy | 2 | 1990 | 945 | 0.030 |
Why?
|
Hospitalization | 1 | 2015 | 10811 | 0.030 |
Why?
|
Peristalsis | 1 | 1995 | 60 | 0.030 |
Why?
|
Iopamidol | 1 | 2015 | 188 | 0.030 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2000 | 1143 | 0.030 |
Why?
|
Lithotripsy, Laser | 2 | 1992 | 43 | 0.030 |
Why?
|
Hepatoblastoma | 1 | 1995 | 90 | 0.030 |
Why?
|
Enema | 1 | 1995 | 140 | 0.030 |
Why?
|
Prostate-Specific Antigen | 1 | 2024 | 2463 | 0.030 |
Why?
|
Drosophila melanogaster | 1 | 2023 | 1725 | 0.030 |
Why?
|
Abdominal Injuries | 1 | 1997 | 362 | 0.030 |
Why?
|
Cholangiopancreatography, Magnetic Resonance | 2 | 2004 | 101 | 0.030 |
Why?
|
Natural Language Processing | 1 | 2023 | 1198 | 0.030 |
Why?
|
Learning | 1 | 2023 | 1755 | 0.030 |
Why?
|
Pneumothorax | 1 | 1997 | 393 | 0.030 |
Why?
|
Muscles | 2 | 1996 | 1576 | 0.030 |
Why?
|
Pancreatic Pseudocyst | 2 | 2005 | 112 | 0.030 |
Why?
|
Genital Neoplasms, Female | 1 | 2019 | 534 | 0.030 |
Why?
|
Ganglia, Sympathetic | 1 | 1993 | 65 | 0.030 |
Why?
|
Mice, Inbred C3H | 1 | 1995 | 915 | 0.030 |
Why?
|
Injections, Intravenous | 1 | 1995 | 1376 | 0.030 |
Why?
|
Adrenal Gland Diseases | 1 | 1994 | 141 | 0.030 |
Why?
|
Glomerular Filtration Rate | 1 | 2022 | 2232 | 0.030 |
Why?
|
Clinical Protocols | 1 | 2019 | 1437 | 0.030 |
Why?
|
Stainless Steel | 2 | 1992 | 79 | 0.030 |
Why?
|
Rural Health Services | 1 | 2017 | 393 | 0.030 |
Why?
|
Neoplasm Transplantation | 2 | 1995 | 2010 | 0.030 |
Why?
|
Autonomic Nerve Block | 1 | 1993 | 83 | 0.030 |
Why?
|
History, 19th Century | 1 | 1995 | 711 | 0.020 |
Why?
|
Corynebacterium diphtheriae | 2 | 1982 | 21 | 0.020 |
Why?
|
Enterocolitis, Pseudomembranous | 1 | 1994 | 264 | 0.020 |
Why?
|
Adrenal Glands | 1 | 1994 | 556 | 0.020 |
Why?
|
Cholecystography | 1 | 1991 | 42 | 0.020 |
Why?
|
Sclerosing Solutions | 1 | 1992 | 80 | 0.020 |
Why?
|
Diatrizoate Meglumine | 1 | 1991 | 80 | 0.020 |
Why?
|
Ethers | 1 | 1991 | 72 | 0.020 |
Why?
|
Research Support as Topic | 1 | 1996 | 697 | 0.020 |
Why?
|
Coronary Vessels | 1 | 2022 | 3094 | 0.020 |
Why?
|
Carcinoembryonic Antigen | 1 | 1992 | 336 | 0.020 |
Why?
|
Water | 2 | 1995 | 1416 | 0.020 |
Why?
|
Hospitals, Teaching | 1 | 1996 | 1156 | 0.020 |
Why?
|
Pleura | 2 | 1992 | 243 | 0.020 |
Why?
|
Fever of Unknown Origin | 1 | 1991 | 94 | 0.020 |
Why?
|
Coronary Angiography | 1 | 2022 | 4498 | 0.020 |
Why?
|
Enterostomy | 1 | 1990 | 14 | 0.020 |
Why?
|
Intestinal Obstruction | 2 | 1991 | 433 | 0.020 |
Why?
|
Cecostomy | 1 | 1990 | 10 | 0.020 |
Why?
|
Electronic Mail | 1 | 2012 | 215 | 0.020 |
Why?
|
Pleural Effusion, Malignant | 1 | 1992 | 108 | 0.020 |
Why?
|
Prognosis | 3 | 2007 | 29912 | 0.020 |
Why?
|
Morbidity | 1 | 2016 | 1753 | 0.020 |
Why?
|
Vaccination | 1 | 2023 | 3431 | 0.020 |
Why?
|
Signal Processing, Computer-Assisted | 2 | 1994 | 1457 | 0.020 |
Why?
|
Solvents | 1 | 1991 | 299 | 0.020 |
Why?
|
Inhalation | 1 | 1990 | 142 | 0.020 |
Why?
|
Ethanol | 2 | 1993 | 1326 | 0.020 |
Why?
|
Thyroid Gland | 1 | 2017 | 1168 | 0.020 |
Why?
|
Methyl Ethers | 1 | 1991 | 196 | 0.020 |
Why?
|
Mitochondria | 1 | 2023 | 3672 | 0.020 |
Why?
|
Methods | 1 | 1990 | 1061 | 0.020 |
Why?
|
Palliative Care | 3 | 1994 | 3639 | 0.020 |
Why?
|
Ascites | 1 | 1991 | 336 | 0.020 |
Why?
|
Inpatients | 1 | 2021 | 2566 | 0.020 |
Why?
|
Head and Neck Neoplasms | 1 | 2004 | 2926 | 0.020 |
Why?
|
Animals | 13 | 2023 | 168800 | 0.020 |
Why?
|
Calcium | 1 | 2022 | 5770 | 0.020 |
Why?
|
Accident Prevention | 1 | 1989 | 76 | 0.020 |
Why?
|
Genetic Variation | 1 | 2004 | 6612 | 0.020 |
Why?
|
Disclosure | 1 | 2015 | 756 | 0.020 |
Why?
|
Intubation, Gastrointestinal | 1 | 1990 | 166 | 0.020 |
Why?
|
Empyema | 1 | 1988 | 41 | 0.020 |
Why?
|
Pleural Diseases | 1 | 1989 | 138 | 0.020 |
Why?
|
Nuclear Energy | 1 | 1988 | 15 | 0.020 |
Why?
|
Computer Simulation | 1 | 2002 | 6254 | 0.020 |
Why?
|
Quantum Theory | 1 | 1988 | 68 | 0.020 |
Why?
|
Ethylenediamines | 1 | 1988 | 57 | 0.020 |
Why?
|
Appendicitis | 2 | 2007 | 680 | 0.020 |
Why?
|
Child, Preschool | 5 | 2015 | 42511 | 0.020 |
Why?
|
Models, Structural | 3 | 1994 | 338 | 0.020 |
Why?
|
Fluorouracil | 2 | 2003 | 1648 | 0.020 |
Why?
|
Laser Therapy | 2 | 1992 | 1108 | 0.020 |
Why?
|
Aneurysm | 1 | 1991 | 343 | 0.020 |
Why?
|
Hyperplasia | 3 | 2001 | 1142 | 0.020 |
Why?
|
Chronic Disease | 1 | 2002 | 9354 | 0.020 |
Why?
|
Edema | 1 | 1991 | 763 | 0.020 |
Why?
|
Faculty, Medical | 1 | 1996 | 1225 | 0.020 |
Why?
|
Diarrhea | 1 | 1994 | 1315 | 0.020 |
Why?
|
Embolization, Therapeutic | 2 | 2014 | 1405 | 0.020 |
Why?
|
Liver Neoplasms, Experimental | 1 | 1988 | 190 | 0.020 |
Why?
|
Arteries | 1 | 2012 | 1121 | 0.020 |
Why?
|
Fellowships and Scholarships | 1 | 1996 | 1134 | 0.020 |
Why?
|
Risk Assessment | 2 | 2009 | 24276 | 0.020 |
Why?
|
Hernia, Abdominal | 1 | 2007 | 58 | 0.020 |
Why?
|
History, 20th Century | 1 | 1995 | 2762 | 0.020 |
Why?
|
Lymphoma, B-Cell | 1 | 1993 | 943 | 0.020 |
Why?
|
Rats | 7 | 1994 | 23717 | 0.020 |
Why?
|
Respiration, Artificial | 1 | 1997 | 2727 | 0.020 |
Why?
|
Kidney Neoplasms | 1 | 2002 | 4282 | 0.020 |
Why?
|
Splenic Vein | 2 | 1997 | 30 | 0.020 |
Why?
|
Intestine, Small | 1 | 1991 | 1216 | 0.020 |
Why?
|
Follow-Up Studies | 7 | 2004 | 39243 | 0.020 |
Why?
|
Pleural Effusion | 1 | 1988 | 344 | 0.020 |
Why?
|
Brain | 2 | 2004 | 27177 | 0.020 |
Why?
|
Renal Veins | 1 | 2005 | 103 | 0.010 |
Why?
|
Radiographic Magnification | 1 | 2004 | 18 | 0.010 |
Why?
|
Anesthesia, General | 1 | 1991 | 1187 | 0.010 |
Why?
|
Abscess | 1 | 1988 | 605 | 0.010 |
Why?
|
Lymphoma, Non-Hodgkin | 2 | 1989 | 1374 | 0.010 |
Why?
|
Antineoplastic Agents | 2 | 2004 | 13635 | 0.010 |
Why?
|
Swine | 3 | 2005 | 5986 | 0.010 |
Why?
|
Hodgkin Disease | 2 | 1989 | 1383 | 0.010 |
Why?
|
Obesity | 1 | 2006 | 13085 | 0.010 |
Why?
|
Adipose Tissue | 1 | 1995 | 3315 | 0.010 |
Why?
|
Pleural Neoplasms | 1 | 1988 | 584 | 0.010 |
Why?
|
Virus Diseases | 1 | 1989 | 720 | 0.010 |
Why?
|
Disease Management | 1 | 2014 | 2531 | 0.010 |
Why?
|
Rats, Inbred Strains | 3 | 1990 | 2077 | 0.010 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 1993 | 1433 | 0.010 |
Why?
|
Antibodies, Antinuclear | 1 | 2004 | 340 | 0.010 |
Why?
|
Papilloma, Intraductal | 1 | 2002 | 21 | 0.010 |
Why?
|
Cost Savings | 2 | 2001 | 901 | 0.010 |
Why?
|
Cystadenocarcinoma, Mucinous | 1 | 2002 | 51 | 0.010 |
Why?
|
Cholestasis, Extrahepatic | 2 | 1994 | 52 | 0.010 |
Why?
|
Health Expenditures | 1 | 2015 | 2389 | 0.010 |
Why?
|
Cystadenoma, Serous | 1 | 2002 | 99 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2002 | 11859 | 0.010 |
Why?
|
Neoplasm Staging | 3 | 2003 | 11200 | 0.010 |
Why?
|
Medicare | 1 | 2020 | 6820 | 0.010 |
Why?
|
Regional Blood Flow | 1 | 2005 | 1479 | 0.010 |
Why?
|
Occupational Diseases | 1 | 1989 | 1456 | 0.010 |
Why?
|
Quality Control | 1 | 2004 | 835 | 0.010 |
Why?
|
Duodenum | 1 | 2004 | 496 | 0.010 |
Why?
|
Case-Control Studies | 2 | 2015 | 22228 | 0.010 |
Why?
|
Intraoperative Care | 1 | 2004 | 768 | 0.010 |
Why?
|
Endosonography | 1 | 2004 | 626 | 0.010 |
Why?
|
Injections | 1 | 2003 | 839 | 0.010 |
Why?
|
Spinal Diseases | 1 | 1985 | 561 | 0.010 |
Why?
|
Rectum | 1 | 2005 | 896 | 0.010 |
Why?
|
Osmolar Concentration | 1 | 2001 | 655 | 0.010 |
Why?
|
Bacterial Infections | 1 | 1988 | 1387 | 0.010 |
Why?
|
Drug Combinations | 2 | 1997 | 2076 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 2005 | 3432 | 0.010 |
Why?
|
Infant | 2 | 2015 | 36427 | 0.010 |
Why?
|
Colorectal Neoplasms | 1 | 2019 | 6961 | 0.010 |
Why?
|
Drug Evaluation | 2 | 1990 | 642 | 0.010 |
Why?
|
Confidence Intervals | 1 | 2004 | 2915 | 0.010 |
Why?
|
Multicenter Studies as Topic | 1 | 2003 | 1729 | 0.010 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2003 | 698 | 0.010 |
Why?
|
Treatment Failure | 2 | 1994 | 2653 | 0.010 |
Why?
|
Gastrointestinal Tract | 1 | 2004 | 834 | 0.010 |
Why?
|
Constriction, Pathologic | 2 | 1991 | 1102 | 0.010 |
Why?
|
Diagnostic Tests, Routine | 1 | 2003 | 789 | 0.010 |
Why?
|
World Health Organization | 1 | 2003 | 1326 | 0.010 |
Why?
|
Chest Tubes | 1 | 1997 | 153 | 0.010 |
Why?
|
Guidelines as Topic | 1 | 2003 | 1394 | 0.010 |
Why?
|
Infant, Newborn | 2 | 2015 | 26381 | 0.010 |
Why?
|
Longitudinal Studies | 2 | 2006 | 14747 | 0.010 |
Why?
|
Diagnostic Errors | 2 | 1996 | 1276 | 0.010 |
Why?
|
Suspensions | 1 | 1996 | 68 | 0.010 |
Why?
|
Linear Models | 1 | 2006 | 5873 | 0.010 |
Why?
|
Cost Control | 1 | 1998 | 626 | 0.010 |
Why?
|
Internship and Residency | 1 | 1996 | 5946 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 1994 | 7474 | 0.010 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2002 | 1086 | 0.010 |
Why?
|
Jejunum | 1 | 1997 | 474 | 0.010 |
Why?
|
Comorbidity | 1 | 2009 | 10579 | 0.010 |
Why?
|
Cholestasis, Intrahepatic | 1 | 1994 | 75 | 0.010 |
Why?
|
Crohn Disease | 1 | 2007 | 2281 | 0.010 |
Why?
|
Dogs | 2 | 1990 | 3824 | 0.010 |
Why?
|
Double-Blind Method | 2 | 1999 | 12426 | 0.010 |
Why?
|
Pain | 1 | 1989 | 5090 | 0.010 |
Why?
|
Sodium Tetradecyl Sulfate | 1 | 1992 | 14 | 0.010 |
Why?
|
Vena Cava, Inferior | 1 | 1996 | 463 | 0.010 |
Why?
|
Particle Size | 1 | 1997 | 1630 | 0.010 |
Why?
|
Pain, Intractable | 1 | 1993 | 132 | 0.010 |
Why?
|
Guinea Pigs | 1 | 1994 | 1300 | 0.010 |
Why?
|
Equipment Failure | 1 | 1994 | 580 | 0.010 |
Why?
|
Surgical Wound Infection | 1 | 1981 | 1544 | 0.010 |
Why?
|
Treatment Outcome | 3 | 2006 | 65219 | 0.010 |
Why?
|
Ascitic Fluid | 1 | 1991 | 189 | 0.010 |
Why?
|
Tetracycline | 1 | 1992 | 216 | 0.010 |
Why?
|
Digestive System Neoplasms | 1 | 1991 | 82 | 0.010 |
Why?
|
Intensive Care Units | 2 | 1997 | 3798 | 0.010 |
Why?
|
Length of Stay | 2 | 1997 | 6490 | 0.010 |
Why?
|
Bleomycin | 1 | 1992 | 491 | 0.010 |
Why?
|
Abdominal Muscles | 1 | 1991 | 172 | 0.010 |
Why?
|
Mutagenicity Tests | 1 | 1990 | 46 | 0.010 |
Why?
|
Ultrasonics | 1 | 1992 | 208 | 0.010 |
Why?
|
Burns | 1 | 1982 | 1904 | 0.010 |
Why?
|
Diatrizoate | 1 | 1990 | 81 | 0.010 |
Why?
|
Mesenteric Arteries | 1 | 1991 | 177 | 0.010 |
Why?
|
Liver Abscess, Amebic | 1 | 1990 | 19 | 0.010 |
Why?
|
Echinococcosis, Hepatic | 1 | 1990 | 23 | 0.010 |
Why?
|
Liver Function Tests | 1 | 1991 | 527 | 0.010 |
Why?
|
Recurrence | 2 | 1992 | 8494 | 0.010 |
Why?
|
Disease Models, Animal | 2 | 2005 | 18321 | 0.010 |
Why?
|
Carcinoid Tumor | 1 | 1991 | 225 | 0.010 |
Why?
|
Mice | 2 | 1995 | 81839 | 0.010 |
Why?
|
Cholangitis | 1 | 1990 | 110 | 0.010 |
Why?
|
Endoscopy, Digestive System | 1 | 1992 | 358 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 1999 | 2689 | 0.010 |
Why?
|
Gases | 1 | 1990 | 205 | 0.010 |
Why?
|
Intubation, Intratracheal | 1 | 1997 | 1359 | 0.010 |
Why?
|
Catheters, Indwelling | 1 | 1991 | 436 | 0.000 |
Why?
|
Bile | 1 | 1990 | 300 | 0.000 |
Why?
|
Intestinal Neoplasms | 1 | 1991 | 314 | 0.000 |
Why?
|
Gangrene | 1 | 1989 | 92 | 0.000 |
Why?
|
Therapeutic Irrigation | 1 | 1990 | 297 | 0.000 |
Why?
|
Multivariate Analysis | 1 | 2002 | 12061 | 0.000 |
Why?
|
Retroperitoneal Space | 1 | 1989 | 175 | 0.000 |
Why?
|
Hemangioendothelioma | 1 | 1989 | 112 | 0.000 |
Why?
|
Suppuration | 1 | 1988 | 60 | 0.000 |
Why?
|
Chemistry | 1 | 1988 | 325 | 0.000 |
Why?
|
Carcinosarcoma | 1 | 1989 | 108 | 0.000 |
Why?
|
Aorta | 1 | 1996 | 2040 | 0.000 |
Why?
|
Chemical Phenomena | 1 | 1988 | 483 | 0.000 |
Why?
|
DNA, Neoplasm | 1 | 1993 | 1739 | 0.000 |
Why?
|
Respiration | 1 | 1994 | 1653 | 0.000 |
Why?
|
Hematoma | 1 | 1992 | 765 | 0.000 |
Why?
|
Neoplasm Invasiveness | 1 | 1996 | 3602 | 0.000 |
Why?
|
Feces | 1 | 1994 | 1503 | 0.000 |
Why?
|
Equipment and Supplies | 1 | 1989 | 273 | 0.000 |
Why?
|
Rats, Inbred F344 | 1 | 1988 | 820 | 0.000 |
Why?
|
Colonoscopy | 1 | 1995 | 1408 | 0.000 |
Why?
|
Myelography | 1 | 1985 | 72 | 0.000 |
Why?
|
Pressure | 1 | 1989 | 1171 | 0.000 |
Why?
|
Disease Progression | 1 | 2002 | 13616 | 0.000 |
Why?
|
Shock, Septic | 1 | 1991 | 771 | 0.000 |
Why?
|
Blood Vessels | 1 | 1990 | 1113 | 0.000 |
Why?
|
Polymerase Chain Reaction | 1 | 1993 | 6059 | 0.000 |
Why?
|
Leiomyoma | 1 | 1989 | 644 | 0.000 |
Why?
|
Cicatrix | 1 | 1989 | 796 | 0.000 |
Why?
|
Rats, Sprague-Dawley | 1 | 1994 | 8113 | 0.000 |
Why?
|
Incidence | 1 | 2001 | 21513 | 0.000 |
Why?
|
Uterine Neoplasms | 1 | 1991 | 1425 | 0.000 |
Why?
|
Base Sequence | 1 | 1993 | 12405 | 0.000 |
Why?
|
Dose-Response Relationship, Drug | 1 | 1994 | 10737 | 0.000 |
Why?
|
Rabbits | 1 | 1988 | 4730 | 0.000 |
Why?
|
Diphtheria | 1 | 1981 | 32 | 0.000 |
Why?
|
Combined Modality Therapy | 1 | 1992 | 8525 | 0.000 |
Why?
|
Molecular Sequence Data | 1 | 1993 | 17597 | 0.000 |
Why?
|
Reoperation | 1 | 1990 | 4309 | 0.000 |
Why?
|
Uterine Cervical Neoplasms | 1 | 1991 | 2040 | 0.000 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 1985 | 3678 | 0.000 |
Why?
|
Ovarian Neoplasms | 1 | 1991 | 4904 | 0.000 |
Why?
|
Postoperative Complications | 1 | 1997 | 15808 | 0.000 |
Why?
|